(CHRD) Chord Energy - Ratings and Ratios
Crude Oil, Natural Gas, Natural Gas Liquids
CHRD EPS (Earnings per Share)
CHRD Revenue
Description: CHRD Chord Energy
Chord Energy Corporation is an independent exploration and production company operating in the United States, primarily focused on acquiring, exploring, developing, and producing crude oil, natural gas, and natural gas liquids in the Williston Basin. The companys products are sold to refiners, marketers, and other purchasers with access to pipeline and rail facilities.
As a key player in the Oil & Gas Exploration & Production sub-industry, Chord Energys performance can be evaluated using key performance indicators (KPIs) such as production growth rate, reserve replacement ratio, and operating costs per barrel of oil equivalent (BOE). The companys operational efficiency and ability to manage costs will be crucial in maintaining its competitiveness in the market.
To further assess Chord Energys financial health and investment potential, we can examine additional KPIs such as debt-to-equity ratio, interest coverage ratio, and return on capital employed (ROCE). A low debt-to-equity ratio and high interest coverage ratio would indicate a stable financial position, while a high ROCE would suggest effective capital allocation. Chord Energys dividend yield and payout ratio can also provide insights into its shareholder return strategy.
Considering the current market environment, Chord Energys ability to navigate the cyclical nature of the oil and gas industry will be critical. The companys hedging strategy, cost structure, and operational flexibility will be essential in maintaining its profitability during periods of low oil prices. By closely monitoring these factors, investors can make informed decisions about Chord Energys investment potential.
CHRD Stock Overview
| Market Cap in USD | 6,393m |
| Sub-Industry | Oil & Gas Exploration & Production |
| IPO / Inception | 2000-02-15 |
CHRD Stock Ratings
| Growth Rating | -17.1% |
| Fundamental | 61.1% |
| Dividend Rating | 77.7% |
| Return 12m vs S&P 500 | -31.7% |
| Analyst Rating | 4.40 of 5 |
CHRD Dividends
| Dividend Yield 12m | 5.03% |
| Yield on Cost 5y | 27.86% |
| Annual Growth 5y | 15.90% |
| Payout Consistency | 93.2% |
| Payout Ratio | 42.0% |
CHRD Growth Ratios
| Growth Correlation 3m | 29% |
| Growth Correlation 12m | -71.7% |
| Growth Correlation 5y | 63.8% |
| CAGR 5y | -1.04% |
| CAGR/Max DD 3y | -0.02 |
| CAGR/Mean DD 3y | -0.09 |
| Sharpe Ratio 12m | 0.14 |
| Alpha | 0.00 |
| Beta | 0.980 |
| Volatility | 34.34% |
| Current Volume | 1053.7k |
| Average Volume 20d | 770.4k |
| Stop Loss | 101.4 (-3.7%) |
| Signal | -0.12 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (265.8m TTM) > 0 and > 6% of Revenue (6% = 318.0m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 4.91pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.00% (prev -1.66%; Δ 0.66pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 2.31b > Net Income 265.8m (YES >=105%, WARN >=100%) |
| Net Debt (916.0m) to EBITDA (1.95b) ratio: 0.47 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.97 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (57.8m) change vs 12m ago 15.77% (target <= -2.0% for YES) |
| Gross Margin 22.44% (prev 31.61%; Δ -9.17pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 41.26% (prev 33.73%; Δ 7.54pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.15 (EBITDA TTM 1.95b / Interest Expense TTM 71.3m) >= 6 (WARN >= 3) |
Altman Z'' 1.22
| (A) -0.00 = (Total Current Assets 1.52b - Total Current Liabilities 1.58b) / Total Assets 12.55b |
| (B) 0.16 = Retained Earnings (Balance) 1.98b / Total Assets 12.55b |
| (C) 0.04 = EBIT TTM 510.0m / Avg Total Assets 12.85b |
| (D) 0.44 = Book Value of Equity 1.98b / Total Liabilities 4.45b |
| Total Rating: 1.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.05
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 18.59% = 5.0 |
| 3. FCF Margin 25.60% = 6.40 |
| 4. Debt/Equity 0.12 = 2.49 |
| 5. Debt/Ebitda 0.49 = 2.32 |
| 6. ROIC - WACC (= -4.45)% = -5.56 |
| 7. RoE 3.11% = 0.26 |
| 8. Rev. Trend 60.33% = 4.52 |
| 9. EPS Trend -77.81% = -3.89 |
What is the price of CHRD shares?
Over the past week, the price has changed by -1.13%, over one month by +4.91%, over three months by -0.15% and over the past year by -19.08%.
Is Chord Energy a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CHRD is around 96.90 USD . This means that CHRD is currently overvalued and has a potential downside of -8.02%.
Is CHRD a buy, sell or hold?
- Strong Buy: 9
- Buy: 3
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CHRD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 133.9 | 27.1% |
| Analysts Target Price | 133.9 | 27.1% |
| ValueRay Target Price | 108.1 | 2.6% |
Last update: 2025-09-04 04:34
CHRD Fundamental Data Overview
CCE Cash And Equivalents = 40.5m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 26.4573
P/S = 1.287
P/B = 0.7772
Beta = 0.843
Revenue TTM = 5.30b USD
EBIT TTM = 510.0m USD
EBITDA TTM = 1.95b USD
Long Term Debt = 918.9m USD (from longTermDebt, last quarter)
Short Term Debt = 29.4m USD (from shortTermDebt, last quarter)
Debt = 948.3m USD (Calculated: Short Term 29.4m + Long Term 918.9m)
Net Debt = 916.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.30b USD (6.39b + Debt 948.3m - CCE 40.5m)
Interest Coverage Ratio = 7.15 (Ebit TTM 510.0m / Interest Expense TTM 71.3m)
FCF Yield = 18.59% (FCF TTM 1.36b / Enterprise Value 7.30b)
FCF Margin = 25.60% (FCF TTM 1.36b / Revenue TTM 5.30b)
Net Margin = 5.02% (Net Income TTM 265.8m / Revenue TTM 5.30b)
Gross Margin = 22.44% ((Revenue TTM 5.30b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Tobins Q-Ratio = 3.69 (Enterprise Value 7.30b / Book Value Of Equity 1.98b)
Interest Expense / Debt = 1.98% (Interest Expense 18.8m / Debt 948.3m)
Taxrate = 23.71% (263.8m / 1.11b)
NOPAT = 389.0m (EBIT 510.0m * (1 - 23.71%))
Current Ratio = 0.97 (Total Current Assets 1.52b / Total Current Liabilities 1.58b)
Debt / Equity = 0.12 (Debt 948.3m / last Quarter total Stockholder Equity 8.10b)
Debt / EBITDA = 0.49 (Net Debt 916.0m / EBITDA 1.95b)
Debt / FCF = 0.70 (Debt 948.3m / FCF TTM 1.36b)
Total Stockholder Equity = 8.55b (last 4 quarters mean)
RoA = 2.12% (Net Income 265.8m, Total Assets 12.55b )
RoE = 3.11% (Net Income TTM 265.8m / Total Stockholder Equity 8.55b)
RoCE = 5.39% (Ebit 510.0m / (Equity 8.55b + L.T.Debt 918.9m))
RoIC = 4.14% (NOPAT 389.0m / Invested Capital 9.41b)
WACC = 8.58% (E(6.39b)/V(7.34b) * Re(9.63%)) + (D(948.3m)/V(7.34b) * Rd(1.98%) * (1-Tc(0.24)))
Shares Correlation 3-Years: 45.45 | Cagr: 2.70%
Discount Rate = 9.63% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 75.80% ; FCFE base≈1.12b ; Y1≈1.33b ; Y5≈2.07b
Fair Price DCF = 469.0 (DCF Value 26.85b / Shares Outstanding 57.3m; 5y FCF grow 19.76% → 3.0% )
EPS Correlation: -77.81 | EPS CAGR: -39.72% | SUE: -0.39 | # QB: 0
Revenue Correlation: 60.33 | Revenue CAGR: -0.25% | SUE: 1.80 | # QB: 1
Additional Sources for CHRD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle